GlassScriptPhysician profile
David S Drummond
NPI 1316383524
$8,569.02
in general payments reported to CMS, 2019-2025
29 companies · $833 in 2025
The $833 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,057 · 2020: $75.26 · 2021: $713 · 2022: $628 · 2023: $1,471 · 2024: $793 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,334 · Travel and Lodging: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,334.05 |
| Travel and Lodging | $762.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $2,275.47 | 2019-2023 | |
| Wright Medical Technology, INC. | $2,173.03 | 2019 | |
| Stryker Corporation | $1,926.76 | 2021-2025 | Prostep Mica, 7 X 23mm Citrelock Implant, Augment Injectable |
| Arthrex, INC. | $482.06 | 2023-2025 | |
| Axogen | $370.98 | 2021-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Smith+Nephew, INC. | $167.70 | 2019-2025 | Stravix, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $132.28 | 2021 | |
| Horizon Therapeutics Plc | $128.04 | 2019-2022 | |
| Averitas Pharma INC. | $115.71 | 2023-2024 | Qutenza |
| Bioventus LLC | $83.45 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Medshape, INC. | $79.83 | 2023 | Dynanail Helix, Washer, 15 Mm |
| Vertex Pharmaceuticals Incorporated | $72.91 | 2024-2025 | |
| Depuy Synthes Sales INC. | $67.97 | 2019-2023 | Fibergraft Bg Morsels, Motoband |
| Dynasplint Systems INC. | $60.59 | 2025 | Dynasplint |
| Organogenesis INC. | $55.86 | 2022-2024 | Cygnus Dual |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $46.71 | 2022-2024 | Iovera, Exparel, Zilretta |
| Ethicon US, LLC | $39.34 | 2021 | |
| Si-Bone, INC. | $38.64 | 2022 | |
| Kci USA, INC. | $37.20 | 2019-2022 | |
| Amgen INC. | $34.88 | 2022-2024 | Krystexxa |
| Glenmark Therapeutics INC. | $30.00 | 2019 | |
| Medtronic, INC. | $29.46 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Innovation Technologies INC | $24.34 | 2024 | Irrisept |
| Abbvie INC. | $21.76 | 2023 | Dalvance |
| Sanofi-Aventis U.S. LLC | $19.11 | 2019 | |
| Heraeus Medical, LLC. | $15.43 | 2025 | |
| Baudax Bio INC. | $14.42 | 2020 | |
| Sanara Medtech INC. | $14.17 | 2021 | |
| Melinta Therapeutics, LLC | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Drummond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.